Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-029621
Filing Date
2008-05-13
Accepted
2008-05-13 16:49:04
Documents
1
Period of Report
2008-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5534
  Complete submission text file 0001209191-08-029621.txt   7426
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Issuer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address BARR LABORATORIES INC 300 CORPORATE DRIVE SUITE 10 BLAUVELT NY 10913 18002275227
KILLION FREDERICK (Reporting) CIK: 0001237261 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09860 | Film No.: 08828152